AARTIPHARM829.05

Aarti Pharmalabs Ltd.

· Pharma & Health
₹ CrorePeersAARTIDRUGSADVENZYMESAGARWALEYEAKUMSALIVUSAPLLTDCORONAHCGMcap ₹7,516 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation73.286.9104.3
+ Impairment Loss / (Reversal)0.013.57.1
+ Finance Costs17.226.946.9
+ Interest Income-3.0-7.1-2.1
+ Dividend Income-0.0-0.10.0
+ Share-based Payments0.00.02.5
+ Unrealised FX (Gain) / Loss0.00.034.7
+ Other Non-cash Items7.31.32.8
+ Other Reconciling Items0.00.0-7.6
Changes in Working Capital
+ Inventories-39.755.3-80.6
+ Trade Receivables — Current-125.5-84.4-97.0
+ Other Non-current Assets0.00.02.6
+ Trade Payables — Current43.3-56.970.2
Cash from Operating Activities
Profit Before Tax (per I/S)300.5360.7224.9267.1
+ Total Adjustments (incl. Working Capital)-27.235.483.9
Cash from Operations (pre-tax)273.3396.1308.9
+ Income Taxes Paid56.964.546.9
Cash from Operating Activities216.4331.6261.9
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)155.6402.0409.4
+ Acq of Intangible Assets43.20.00.0
+ Acq of Intangibles under Development0.041.838.9
+ Sale of Investments (Equity / Debt)0.022.812.5
+ Loans & Advances Repaid0.00.02.9
+ Dividends Received — Investing0.00.10.0
+ Interest Received — Investing3.07.12.1
+ Other Inflows / (Outflows) — Investing-18.90.00.0
Cash from Investing Activities-214.6-413.9-430.7
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.00.0
+ Proceeds from Exercise of Stock Options0.00.00.0
+ Proceeds from Borrowings50.0127.9264.2
+ Payment of Lease Liabilities0.06.218.7
+ Payment of Finance Lease Liabilities4.9
+ Interest Paid17.224.538.7
+ Dividends Paid18.131.736.3
Cash from Financing Activities9.765.4170.6
Net Changes in Cash (pre-FX)11.5-16.91.8
Net Changes in Cash11.5-16.91.8
Closing Cash23.6
Reference Items
EBITDA386.0464.4369.2426.3
EBITDA Margin %20.8421.9620.2921.65
Free Cash Flow (CFO − Capex)17.6-70.5-147.4-147.4
Free Cash Flow to Equity37.3103.1
Free Cash Flow per Basic Share1.94-7.77-16.26-16.26
Cash Flow to Net Income1.001.221.50
Cash Paid for Taxes56.964.546.9
Cash Paid for Interest17.224.538.7
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.